MCM
Matterhorn Capital Management Portfolio holdings
AUM
$151M
1-Year Return
14.71%
This Quarter Return
+4.21%
1 Year Return
+14.71%
3 Year Return
+38.71%
5 Year Return
–
10 Year Return
–
AUM
$219M
AUM Growth
+$11.4M
(+5.5%)
Cap. Flow
+$6.29M
Cap. Flow
% of AUM
2.87%
Top 10 Holdings %
Top 10 Hldgs %
30.3%
Holding
58
New
5
Increased
35
Reduced
6
Closed
10
Top Buys
| 1 |
Merck
MRK
|
+$6.22M |
| 2 |
Microsoft
MSFT
|
+$5.48M |
| 3 |
SBNY
Signature Bank
SBNY
|
+$4M |
| 4 |
Biogen
BIIB
|
+$3.81M |
| 5 |
Expeditors International
EXPD
|
+$3.42M |
Top Sells
| 1 |
Eli Lilly
LLY
|
+$6.96M |
| 2 |
CF Industries
CF
|
+$5.17M |
| 3 |
HP
HPQ
|
+$4.09M |
| 4 |
Wabtec
WAB
|
+$3.35M |
| 5 |
Middleby
MIDD
|
+$3.32M |
Sector Composition
| 1 | Financials | 26.11% |
| 2 | Healthcare | 23.01% |
| 3 | Technology | 21.15% |
| 4 | Communication Services | 7.41% |
| 5 | Energy | 5.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
26
DELISTED
Celgene Corp
CELG
| $4.01M | 1.83% |
33,469
+4,655
| +16% | +$557K |
|
|
SBNY
27
DELISTED
Signature Bank
SBNY
| $4M | 1.83% |
+26,049
| New | +$4M |
|
28
Apple
AAPL
$3.37T
| $3.97M | 1.81% |
150,844
+17,448
| +13% | +$459K |
|
29
Gilead Sciences
GILD
$143B
| $3.82M | 1.74% |
37,738
+4,974
| +15% | +$503K |
|
|
30
Biogen
BIIB
$20.9B
| $3.81M | 1.74% |
+12,427
| New | +$3.81M |
|
31
Cognizant
CTSH
$33.8B
| $3.73M | 1.7% |
62,066
+7,874
| +15% | +$473K |
|
32
Pfizer
PFE
$140B
| $3.7M | 1.69% |
120,766
+15,486
| +15% | +$474K |
|
33
Schlumberger
SLB
$53.9B
| $3.69M | 1.69% |
52,945
+16,131
| +44% | +$1.13M |
|
34
McKesson
MCK
$87.8B
| $3.66M | 1.67% |
18,537
+3,718
| +25% | +$733K |
|
35
F5
FFIV
$18.8B
| $3.58M | 1.64% |
36,941
+10,678
| +41% | +$1.04M |
|
|
36
Expeditors International
EXPD
$16.5B
| $3.42M | 1.56% |
+75,790
| New | +$3.42M |
|
37
Autoliv
ALV
$9.63B
| $3.33M | 1.52% |
37,029
+119
| +0.3% | +$10.7K |
|
38
Unilever
UL
$154B
| $3.28M | 1.5% |
75,993
-425
| -0.6% | -$18.3K |
|
39
Sleep Number
SNBR
$211M
| $3.26M | 1.49% |
152,240
+21,215
| +16% | +$454K |
|
40
TSMC
TSM
$1.35T
| $3.25M | 1.49% |
142,940
+1,759
| +1% | +$40K |
|
41
Novartis
NVS
$245B
| $3.09M | 1.41% |
40,111
-16
| -0% | -$1.23K |
|
|
RDS.A
42
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $2.92M | 1.33% |
63,736
-1,083
| -2% | -$49.6K |
|
|
SHPG
43
DELISTED
Shire pic
SHPG
| $2.9M | 1.33% |
14,168
+104
| +0.7% | +$21.3K |
|
44
Sumitomo Mitsui Financial
SMFG
$108B
| $2.85M | 1.3% |
375,802
-3,195
| -0.8% | -$24.2K |
|
45
ASML
ASML
$312B
| $2.8M | 1.28% |
31,582
+303
| +1% | +$26.9K |
|
46
Barclays
BCS
$71.8B
| $2.62M | 1.19% |
215,289
-1,483
| -0.7% | -$18K |
|
47
Prosperity Bancshares
PB
$6.4B
| $2.25M | 1.03% |
47,000
| – | – |
|
48
Scotiabank
BNS
$79.4B
| $2.17M | 0.99% |
54,858
-824
| -1% | -$32.6K |
|
49
Blackrock
BLK
$171B
| – | – |
-10,290
| Closed | -$3.06M |
|
|
50
CF Industries
CF
$14.1B
| – | – |
-115,227
| Closed | -$5.17M |
|